Most Recent
Ariosa infringed Sequenom’s patent for prenatal genetic test, court finds
Adrian Ryan 2019-07-01 10:07 pm By Cat Fredenburgh Melbourne

A court has found Ariosa Diagnostics infringed a patent held by Sequenom for a noninvasive prenatal genetic test, and ruled one claim of the patent invalid for lack of fair basis.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Judge crushes Monster Energy’s opposition to monster wheel trade marks
Bruce Caine 2019-06-21 10:05 pm By Cat Fredenburgh Melbourne

A judge has allowed a company associated with leading tyre retailer Bob Jane T-Mart to register three trade marks for its brand of Monster alloy wheels, dismissing claims from US energy drink giant Monster Energy that allowing the registration would lead to confusion.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Grand Theft Auto modder confident of defence in Take-Two copyright case
Bird & Bird 2019-06-21 1:11 pm By Miklos Bolza Sydney

A developer of what’s now being called the “Infamous Mod” for video game Grand Theft Auto, which gives players extra powers, is confident he can defend the copyright case brought against him by Take-Two Interactive and its subsidiary Rockstar Games.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Novartis patent for oral form of top-selling MS drug obvious, IP Australia says
Christian Dimitriadis 2019-05-13 12:31 pm By Miklos Bolza Sydney

A proposed Novartis patent for an oral form of its top-selling multiple sclerosis drug Gilenya is invalid for lack of inventive step, IP Australia has found, but gave the pharmaceutical giant a chance to amend.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Janssen, Alphapharm lay down swords in long-running battle over HIV drug patent
Davies Collison Cave 2019-05-06 12:03 pm By Cat Fredenburgh Melbourne

Drug maker Janssen will drop its long-running patent lawsuit against Alphapharm after the generic drug maker agreed to refrain from making products that allegedly infringe Janssen’s patents for its HIV drug Prezista.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

B. Braun drops appeal after IV catheter patents invalidated
Davies Collison Cave 2019-04-29 9:12 pm By Cat Fredenburgh Melbourne

German medical device company B. Braun Melsungen has dropped its appeal of a ruling invalidating three of its intravenous catheter patents and finding rival Becton Dickinson did not infringe the patents.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Generic drug maker Juno can’t withdraw admission ahead of trial over Velcade patent
Article 2019-04-24 1:32 pm By Christine Caulfield Melbourne

A judge has refused an application by generic drug maker Juno Pharmacueticals to withdraw an admission in a battle with Millennium Pharmaceuticals over its cheap version of breakthrough cancer drug Velcade, denying Juno a potential defence to allegations of patent infringement.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Xenith takeover battle to heat up after regulator signs off on IPH bid
Baker McKenzie 2019-03-28 1:26 pm By Cat Fredenburgh Melbourne

The battle to acquire IP services company Xenith IP Group is set to intensify after the Australian Competition and Consumer Commission blessed a hostile offer by IPH Limited.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

ACCC won’t block $285M merger to create IP law giant
Baker McKenzie 2019-03-21 8:10 pm By Cat Fredenburgh Sydney

The Australian Competition and Consumer Commission will not oppose the merger of two companies that own some of Australia’s largest intellectual property boutiques.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

B. Braun launches appeal in IV catheter patent case
David Shavin 2018-12-05 12:23 pm By Christine Caulfield Melbourne

Medical device maker B. Braun Melsungen is appealing a ruling that invalidated its intravenous catheter patents and dismissed allegations of infringement against rival Becton Dickinson.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?